STAT3 and B-cell chronic lymphocytic leukemia: Moreover, the kinase inhibitor Ibrutinib lowers cytokine levels in CLL patients (Bachireddy and Wu, 2016) and prevents STAT3-phosphorylation in the pseudofollicle model regardless of LDLs (Supplementary Fig. 5).